Quercetin can reduce viral RNA level of O'nyong-nyong virus and resulting innate immune cytokine responses in cultured human synovial fibroblasts.
Alphavirus Infections
/ drug therapy
Caffeic Acids
/ pharmacology
Chemokine CCL2
/ genetics
Chlorogenic Acid
/ pharmacology
Curcumin
/ pharmacology
Cytokines
/ genetics
Fibroblasts
/ virology
Gallic Acid
/ pharmacology
Humans
Immunity, Innate
/ drug effects
Interleukin-1beta
/ genetics
O'nyong-nyong Virus
/ genetics
Quercetin
/ pharmacology
Synovial Fluid
/ drug effects
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 03 2021
18 03 2021
Historique:
received:
04
11
2020
accepted:
08
03
2021
entrez:
19
3
2021
pubmed:
20
3
2021
medline:
12
10
2021
Statut:
epublish
Résumé
O'nyong-nyong virus is an alphavirus closely related to chikungunya virus, causing arthralgia, rash and fever. Alphaviruses mainly target synovial fibroblasts and persists in the joints of patients, possibly leading to chronic arthritis. To date, no specific antiviral treatment is available for ONNV infection and induced-inflammation. Primary human synovial fibroblasts cells were used to assess infection by ONNV and the resulting cytokine responses. Phenolics (gallic acid, caffeic acid and chlorogenic acid, curcumin and quercetin) and a curcuminoids-rich extract from turmeric were tested for their antiviral and anti-inflammatory capacities. We showed that infection occurred in HSF cells and increased gene expression and protein secretion of two major proinflammatory CCL-2 and IL-1β markers. In ONNV-infected HSF cells (MOI 1), we found that non-cytotoxic concentrations of phenolics (10 µM) reduced the level of viral RNA (E1, E2, nsP1, nsP2) and downregulated CCL-2 and IL-1β expression and secretion. These results highlighted the high value of the flavonol quercetin to reduce viral RNA levels and inflammatory status induced by ONNV in HSF cells.
Identifiants
pubmed: 33737658
doi: 10.1038/s41598-021-85840-z
pii: 10.1038/s41598-021-85840-z
pmc: PMC7973764
doi:
Substances chimiques
Caffeic Acids
0
Chemokine CCL2
0
Cytokines
0
IL1B protein, human
0
Interleukin-1beta
0
Chlorogenic Acid
318ADP12RI
Gallic Acid
632XD903SP
Quercetin
9IKM0I5T1E
Curcumin
IT942ZTH98
caffeic acid
U2S3A33KVM
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6369Références
Trans R Soc Trop Med Hyg. 1965 May;59:300-6
pubmed: 14298035
J Virol. 2007 Jan;81(2):872-83
pubmed: 17093195
Molecules. 2017 Mar 22;22(3):
pubmed: 28327521
J Med Food. 2013 Apr;16(4):274-9
pubmed: 23566054
Pathog Glob Health. 2017 Sep;111(6):271-275
pubmed: 28829253
Front Plant Sci. 2015 Aug 25;6:655
pubmed: 26379683
Parasit Vectors. 2014 Mar 28;7:130
pubmed: 24678592
Biofactors. 2016 Jul 8;42(4):418-30
pubmed: 27094023
Chem Biol Drug Des. 2019 Dec;94(6):2023-2030
pubmed: 31436895
Eur J Drug Metab Pharmacokinet. 2019 Apr;44(2):169-177
pubmed: 30328058
Arthritis Rheum. 2012 May;64(5):1329-37
pubmed: 22143988
PLoS Negl Trop Dis. 2019 Jan 17;13(1):e0006919
pubmed: 30653504
Trends Microbiol. 2015 Jan;23(1):35-43
pubmed: 25449049
FEBS J. 2005 Sep;272(18):4725-40
pubmed: 16156793
J Virol Methods. 2015 Feb;212:1-7
pubmed: 25446514
J Immunol Res. 2017;2017:7529408
pubmed: 29387733
Curr Infect Dis Rep. 2011 Jun;13(3):218-28
pubmed: 21465340
Infect Ecol Epidemiol. 2015 Dec 18;5:29853
pubmed: 26689654
Am J Trop Med Hyg. 2013 Jun;88(6):1170-9
pubmed: 23568285
J Clin Pharmacol. 2001 May;41(5):492-9
pubmed: 11361045
J Viral Hepat. 2012 Feb;19(2):e81-8
pubmed: 22239530
J Virol. 2004 Oct;78(20):11334-9
pubmed: 15452254
Clin Infect Dis. 2008 Aug 15;47(4):469-75
pubmed: 18611153
Biomed Res Int. 2013;2013:973516
pubmed: 24069610
RMD Open. 2017 Oct 15;3(2):e000471
pubmed: 29081987
Biomol Ther (Seoul). 2019 May 1;27(3):241-253
pubmed: 31006180
Viruses. 2018 May 03;10(5):
pubmed: 29751486
Biomedicines. 2020 May 21;8(5):
pubmed: 32455629
Int J Mol Sci. 2018 May 25;19(6):
pubmed: 29799460
Arch Pharm Res. 2005 Nov;28(11):1293-301
pubmed: 16350858
J Virol. 2003 Feb;77(3):1691-702
pubmed: 12525603
Lancet. 2012 Feb 18;379(9816):662-71
pubmed: 22100854
Am J Clin Nutr. 2010 Apr;91(4):1044-59
pubmed: 20181810
Virol J. 2011 Oct 04;8:460
pubmed: 21967756
Stem Cell Res Ther. 2019 Aug 19;10(1):260
pubmed: 31426847
PLoS Negl Trop Dis. 2018 Aug 3;12(8):e0006634
pubmed: 30074983
Adv Food Nutr Res. 2019;90:183-257
pubmed: 31445596
Vaccines (Basel). 2020 May 05;8(2):
pubmed: 32380760
Sci Rep. 2016 Aug 22;6:31819
pubmed: 27545976
Antiviral Res. 2009 Jan;81(1):77-81
pubmed: 18992773
Int J Mol Sci. 2019 Oct 10;20(20):
pubmed: 31658782
Viruses. 2015 Dec 25;8(1):
pubmed: 26712783
Viruses. 2018 Feb 09;10(2):
pubmed: 29425115
Ann Ist Super Sanita. 2007;43(4):348-61
pubmed: 18209268
Stain Technol. 1973 May;48(3):135-6
pubmed: 4122196
Biochem Pharmacol. 2010 Dec 15;80(12):1771-92
pubmed: 20599773
Phytother Res. 2021 Jan;35(1):3-5
pubmed: 32757241
PLoS Negl Trop Dis. 2012;6(3):e1446
pubmed: 22479654
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Microorganisms. 2019 May 14;7(5):
pubmed: 31091828
Best Pract Res Clin Rheumatol. 2020 Aug;34(4):101502
pubmed: 32312678
Sci Rep. 2015 Jun 16;5:11421
pubmed: 26078201
Emerg Infect Dis. 2014 Oct;20(10):1766-7
pubmed: 25271361
Viruses. 2019 Mar 22;11(3):
pubmed: 30909385
J Nutr. 2000 Aug;130(8S Suppl):2073S-85S
pubmed: 10917926
J Immunol. 2010 May 15;184(10):5914-27
pubmed: 20404278
Curr Opin Rheumatol. 2004 Jul;16(4):374-9
pubmed: 15201600
Pharmacol Res Perspect. 2017 Jan 23;5(1):e00293
pubmed: 28596841
Asian Pac J Trop Med. 2016 Jan;9(1):1-7
pubmed: 26851778